The IMF’s Understanding series of cancer information booklets is designed to acquaint you with specific multiple myeloma-related tests, treatments and therapies, supportive care measures, and common adverse events.
This publication discusses what myeloma patients should consider if enrolling in a clinical trial.
This publication explains the use of Darzalex (daratumumab) as a line of treatment for myeloma patients.
This publication discusses the use of dexamethasone and other steroids for the treatment of myeloma, as well as possible steroid side effects.
This publication discusses the use of Empliciti (elotuzumab)—a monoclonal antibody—for the treatment of myeloma.
This publication discusses the use of Farydak (panobinostat)—a histone deactlylase (HDAC) inhibitor—for the treatment of myeloma
This publication discusses how to cope with fatigue caused by anemia and other factors related to the underlying disease.